PRIMARY EWING'S SARCOMA: 75% DISEASE-FREE 5 YEAR SURVIVAL WITH T-2 CHEMOTHERAPY – CONSIDERATIONS FOR FUTURE THERAPEUTIC TRIALS | Publicación